These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18404599)

  • 1. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
    Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
    Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
    Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
    Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial effect of probucol and cilostazol in focal ischemic mice with hypercholesterolemia.
    Kim JH; Park SH; Bae SS; Hong KW; Kim YD; Park KP; Choi BT; Shin HK
    J Pharmacol Exp Ther; 2011 Aug; 338(2):451-7. PubMed ID: 21546537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.
    Lee JH; Oh GT; Park SY; Choi JH; Park JG; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
    J Pharmacol Exp Ther; 2005 May; 313(2):502-9. PubMed ID: 15734902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC; Zhao SP; Wu ZH
    Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects.
    Wang Y; Bai L; Lin Y; Guan H; Zhu N; Chen Y; Li Y; Gao S; Zhao S; Fan J; Liu E
    Histol Histopathol; 2014 Dec; 29(12):1593-600. PubMed ID: 25078428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice.
    Zhu H; Jin X; Zhao J; Dong Z; Ma X; Xu F; Huang W; Liu G; Zou Y; Wang K; Hu K; Sun A; Ge J
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):620-7. PubMed ID: 25714599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
    Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
    Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and diet-aggravated hemolysis and its correction by probucol in SR-BI knockout mice with LDL-R deficiency.
    Liao J; Gao M; Wang M; Guo X; Huang W; Liu G
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):48-53. PubMed ID: 25983325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.
    Wang Y; Bai L; Lin Y; Chen Y; Guan H; Zhu N; Li Y; Gao S; Sun L; Zhao S; Fan J; Liu E
    Lipids Health Dis; 2015 Jul; 14():82. PubMed ID: 26220196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice.
    Takase H; Hashimoto A; Okutsu R; Hirose Y; Ito H; Imaizumi T; Miyakoda G; Mori T
    Arzneimittelforschung; 2007; 57(4):185-91. PubMed ID: 17515288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice.
    Benson GM; Schiffelers R; Nicols C; Latcham J; Vidgeon-Hart M; Toseland CD; Suckling KE; Groot PH
    Atherosclerosis; 1998 Dec; 141(2):237-47. PubMed ID: 9862172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.